Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Pdgfα signaling helps maintain fat cells in the skin and is important for hair growth, wound healing, and fighting infections.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Targeting ornithine decarboxylase can help prevent skin cancer.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

DPC-Exos can help regenerate hair follicles and heal wounds by activating the Wnt/β-catenin pathway.

Rat dermal papilla cells have unique properties and interact differently with their environment compared to other skin cells.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

New methods efficiently isolate dermal papilla cells from hair follicles, preserving their characteristics better than traditional methods.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Two patients with stubborn hair loss grew hair after PDRN injections.

PICAT is a reliable tool for assessing dermatology residents' skills in PRP procedures for hair loss.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

PDGF signaling is crucial for maintaining fat stem cells in the skin, and its level of activation can either preserve these cells or cause fibrosis.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

PBM therapy improves mitochondrial function and promotes tissue regeneration in dental pulp stem cells.

Dermal papilla cells can help regrow hair and are promising for hair loss treatments.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

A new method improves the isolation of hair follicle cells for better hair growth research.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.